@article{RN380,

title = {The Canadian version of the NIH minimum dataset for chronic low back pain research: reference values from the Quebec Low Back Pain Study},

author = {A. Angarita-Fonseca and M. G. Pag\'{e} and Carolina B. Meloto and Erika Lauren Gentile and Guillaume L\'{e}onard and Hugo Mass\'{e}-Alarie and Iulia Tufa and Jean-S\'{e}bastien Roy and Laura S. Stone and Manon Choini\`{e}re and Maryse Fortin and Mathieu Roy and Monica Sean and Pascal T\'{e}treault and Pierre Rainville and Simon Deslauriers and A. Lacasse},

url = {https://journals.lww.com/pain/Fulltext/2023/02000/The_Canadian_version_of_the_National_Institutes_of.15.aspx},

doi = {10.1097/j.pain.0000000000002703},

issn = {0304-3959},

year  = {2023},

date = {2023-01-21},

urldate = {2023-01-21},

journal = {PAIN},

volume = {64},

issue = {2},

pages = {325-335},

abstract = {The National Institutes of Health (NIH) minimum dataset for chronic low back pain (CLBP) was developed in response to the challenge of standardizing measurements across studies. Although reference values are critical in research on CLBP to identify individuals and communities at risk of poor outcomes such as disability, no reference values have been published for the Quebec (Canada) context. This study was aimed to: 1) provide reference values for the Canadian version of the NIH minimum dataset among individuals with CLBP in Quebec, both overall and stratified by gender, age, and pain impact stratification (PIS) subgroups; and 2) assess the internal consistency of the minimum dataset domains (pain interference (PI), physical function (PF), emotional distress/depression (EDD), sleep disturbance (SD), and PIS score). We included 2847 individuals living with CLBP who completed the baseline web survey of the Quebec Low Back Pain Study (age: 44.0±11.2 years, 48.1% women), and were recruited through social media and health care settings. The mean score was 6.1±1.8 for pain intensity. PI, PF, EDD, SD, and PIS scores were 12.9±4.1, 14.4±3.9, 9.8±4.4, 13.0±3.6, and 26.4±6.6, respectively. EDD showed floor effects. Good to excellent internal consistency was found overall and by language, gender, and age subgroups for all domains (alpha: 0.81-0.93) and poor to excellent internal consistency for PIS subgroups (alpha: 0.59\textendash0.91). This study presents reference values and recommendations for using the Canadian version of the NIH minimum dataset for CLBP that can be useful for researchers and clinicians. },

keywords = {2023, Back pain, Chronic Pain, Low Back Pain, Pain Measurement},

pubstate = {published},

tppubtype = {article}

}

@article{pmid36444387,

title = {Distinct care trajectories among persons living with arthritic conditions: A two-year state sequence analysis},

author = {H. L. Nguena Nguefack and M. G. Pag\'{e} and M. Choini\`{e}re and A. Vanasse and S. Deslauriers and A. Angarita-Fonseca and M. A. Blanchette and A. Lacasse},

doi = {10.3389/fpain.2022.1014793},

issn = {2673-561X},

year  = {2022},

date = {2022-11-12},

urldate = {2022-01-01},

journal = {Front Pain Res (Lausanne)},

volume = {3},

pages = {1014793},

abstract = {OBJECTIVES: Developing solutions to optimize care trajectories (CareTs) requires examining patient journeys through the health care system. This study aimed to describe CareTs among people living with arthritis and evaluate their association with self-reported health outcomes.



METHODS: Analyses were conducted using the TorSaDE Cohort ( = 102,148), which connects the 2007 to 2016 Canadian Community Health Surveys (CCHS) with Quebec administrative databases (longitudinal claims). CareTs of participants living with arthritis according to CCHS ( = 16,631), over the two years before CCHS completion, were clustered using state sequence analysis (months as a time unit). CareT group membership was then put in association with self-reported outcomes (pain intensity and interference, self-perceived general and mental health).



RESULTS: The analysis revealed five CareT groups characterized predominantly by: (1) arthritis-related visits to a specialist ( = 2,756; 16.6%), (2) arthritis-related emergency department visits ( = 2,928; 17.6%), (3) very high all-cause health care utilization and arthritis-related hospitalizations ( = 1,570; 9.4%), (4) arthritis-related medical visits to general practitioners and specialists ( = 2,708; 16.3%), (5) low all-cause health care utilization ( = 6,669; 40.1%). Multivariable results revealed that CareT group membership was associated with higher levels of pain interference (CareT group #3 vs. #5: OR: 1.4, 95%CI: 1.1-1.8) and fair/poor self-perceived general health (CareT group #1 vs. #5: OR: 1.551, 95%CI: 1.319-1.824; #2 vs. #5: OR: 1.244, 95%CI: 1.062-1.457; #3 vs. #5: OR: 1.771, 95%CI: 1.451-2.162; #4 vs. #5: OR: 1.481, 95%CI: 1.265-1.735).



DISCUSSION: Sate sequence analysis is an innovative method of studying CareTs and valuable for making evidence-based decisions taking into account inter- and intra-individual variability.},

keywords = {Health services, Musculoskeletal system, Trends},

pubstate = {published},

tppubtype = {article}

}

@article{JA0622,

title = {Handgrip strength is associated with risk of falls in physically active older women},

author = {P. C. VillamizarPita and A. Angarita-Fonseca and H. C. Dutra de Souza and R. Mart\'{i}nez-Rueda and M. C. Villamizar-Garc\'{i}a and J. C. S\'{a}nchez-Delgado},

doi = {10.1080/07399332.2022.2055759},

year  = {2022},

date = {2022-05-13},

urldate = {2022-05-13},

journal = {Health care for women international},

pages = {1-14},

abstract = {The authors of this study inquire about the association between handgrip strength (HGS) and the risk of falls in physically active older women. A cross-sectional study was conducted on 135 women between 50 and 90 years of age who were referred for the follow-up evaluations of HGS using dynamometry and the Tinetti scale to determine the risk of falls. The mean age was 68.8 ± 8.5 years. A total of 31.9% of women had a high risk of falls, and 55% reported five or more falls in the past six months. In addition, our results indicated that grip strength decreases as risk of falls increases (minimal risk = 42.8, 95% confidence interval [CI]: 39.8, 45.8; moderate risk = 31.3, 95% CI: 29.1, 33.5; high risk = 21.9, 95% CI: 19.3, 24.6). It should be considered that in physically active women aged over 50 years, the grip strength could be a predictor of falls and risk of falls. Evaluation of grip strength is a low-cost type of assessment that can be included as a part of physical tests.},

keywords = {Muscle Strength, Physical Activity},

pubstate = {published},

tppubtype = {article}

}

@article{JA0522,

title = {Gender differences in medication adverse effects experienced by people living with chronic pain},

author = {H. L. Nguena Nguefack and M. G. Pag\'{e} and L. Gu\'{e}nette and L. Blais and M. Diallo and M. Godbout-Parent and A. Angarita-Fonseca and A. Lacasse},

doi = {10.3389/fpain.2022.830153},

year  = {2022},

date = {2022-05-10},

journal = {Frontiers in Pain Research},

volume = {3},

number = {830153},

abstract = {Objectives: Understanding gender differences in chronic pain (CP) outcome research is essential to optimal treatment delivery. This study explored the associations between gender identity, gender roles, and the number of non-life-threatening pain medication adverse effects reported as severe by people living with CP.



Methods: The analyses were conducted using the COPE Cohort, a dataset generated through a web-based recruitment of adults with CP. Participants were asked how they identified themselves (women, men, unknown, unspecified) and gender roles were measured using the Bem Sex-Role Inventory (subgroups were formed applying the median split method). Pain medication adverse effects were assessed using a standardized checklist (none/mild/moderate/severe). A zero-inflated Poisson model was used to assess gender identity, gender roles and their interaction as potential predictors of the number of pain medication adverse effects.



Results: A total of 1,343 participants reported using pain medications. Adjusting for potential confounders, both gender identity (men vs. women: \ss = −0.32, p = 0.0024) and gender roles (androgynous vs. undifferentiated: \ss = 0.26, p = 0.0030) were associated with the number of pain medication adverse effects reported as severe, and they interacted with each other. The stratified analysis by gender roles showed that women reported a greater number of severe adverse effects than men among those classified as masculine and androgynous.



Discussion: Although we are unable to confirm whether the associations can be explained by differences in the experience or in the reporting of effects, gender identity and gender roles should both be explored when studying pain medication adverse effects.},

key = {sex, gender, chronic pain, adverse effects, side effects},

keywords = {Chronic Pain, Pharmacoepidemiology, Women's health},

pubstate = {published},

tppubtype = {article}

}

@article{JA0422,

title = {Prevalence of Cannabis Use for Pain Management in Quebec: A Post-Legalization Estimate Among Generations Living with Chronic Pain},

author = {M. Godbout-Parent and H. L. Nguena Nguefack and A. Angarita-Fonseca and C. Audet and A. Bernier and G. Zahlan and N. Julien and M. G. Pag\'{e} and L Guenette and L. Blais and A. Lacasse},

url = {https://www.tandfonline.com/doi/epub/10.1080/24740527.2022.2051112?needAccess=true, CJP},

doi = {https://doi.org/10.1080/24740527.2022.2051112},

year  = {2022},

date = {2022-03-30},

urldate = {2022-03-30},

journal = {Canadian Journal of Pain},

abstract = {Background

While medical cannabis has been legal in Canada since 2001, recreational cannabis was legalized in October 2018 which has led to a widespread increase in the accessibility of cannabis products.

Aims

This study aimed to estimate the prevalence of cannabis use among adults living with chronic pain (CP) and investigate the relationship between age and cannabis use for CP management.

Methods

A cross-sectional analysis of the COPE Cohort dataset, a large Quebec sample of 1,935 adults living with CP, was conducted. Participants completed a web-based questionnaire in 2019 that contained three yes/no questions about past-year use of cannabis (i.e., for pain management, management of other health-related conditions, recreational purposes).

Results

Among the 1,344 participants who completed the cannabis use section of the questionnaire, the overall prevalence of cannabis use for pain management was 30.1% (95%CI:27.7-32.7). Differences were found between age groups with the highest prevalence among participants aged ≤26 years (36.5%) and lowest for those aged ≥74 years (8.8%). A multivariable logistic model revealed that age, region of residence, generalized pain, use of medications or non-pharmacological approaches for pain management, alcohol/drug consumption, and smoking were associated with the likelihood of using cannabis for pain management.

Conclusions

Cannabis is a common treatment for the management of CP, especially in younger generations. The high prevalence of use emphasizes the importance of better knowledge translation for people living with CP, rapidly generating evidence regarding the safety and efficacy of cannabis, and clinicians’ involvement in supporting people who use cannabis for pain management.},

keywords = {Chronic Pain, Pharmacoepidemiology},

pubstate = {published},

tppubtype = {article}

}